Mealey's (February 1, 2017, 12:51 PM EST) -- LOUISVILLE, Ky. — A Kentucky federal judge on Jan. 4 dismissed without prejudice a lawsuit filed by a woman who claimed that the diabetes drug Farxiga caused her to develop diabetic ketoacidosis (Anna House v. Bristol-Myers Squibb Company, et al., No. 15-894, W.D. Ky., Louisville Div., 2016 U.S. Dist. LEXIS 180869)....